AR032158A1 - Compuestos para tratar el desacomodamiento fundico, composiciones farmaceuticas que los comprenden, proceso para preparar dichas composiciones y proceso para preparar tales compuestos - Google Patents
Compuestos para tratar el desacomodamiento fundico, composiciones farmaceuticas que los comprenden, proceso para preparar dichas composiciones y proceso para preparar tales compuestosInfo
- Publication number
- AR032158A1 AR032158A1 ARP010102955A ARP010102955A AR032158A1 AR 032158 A1 AR032158 A1 AR 032158A1 AR P010102955 A ARP010102955 A AR P010102955A AR P010102955 A ARP010102955 A AR P010102955A AR 032158 A1 AR032158 A1 AR 032158A1
- Authority
- AR
- Argentina
- Prior art keywords
- 4alkyl
- alkyl
- aminocarbonyl
- phenyl
- hydroxycarbonyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 11
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 9
- -1 cyano, nitro, amino Chemical group 0.000 abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical group 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- 229910052717 sulfur Chemical group 0.000 abstract 3
- 239000011593 sulfur Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000001721 carbon Chemical group 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 101100490437 Mus musculus Acvrl1 gene Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 238000003723 Smelting Methods 0.000 abstract 1
- 230000004308 accommodation Effects 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004951 trihalomethoxy group Chemical group 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuestos de formula (1), formas estereoquímicamente isoméricas de los mismos, N-oxidos de los mismos, sales de adicion farmacéuticamente aceptables de los mismos o sales de amonio cuaternario de los mismos, en donde -a1=a2-a3=a4-es un radical bivalente de formula -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=N-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -CH=N-N=CH-, -CH=N-CH=N-, o ûCH=CH-N=N-; -Z1-Z2 es un radical bivalente de formula ûY1-CH(R4)-CH2-, -Y1-CH(R4)-O-, -Y1-CH(R4)-CH2-O-, -Y1-CH(R4)-CH2-S-, -Y1-CH(R4)-CH2-NH-, -Y1-CH(R4)-CH2-CH2-, -Y1-CH(R4)-CH2-CH2-CH2-, -Y1-CH(R4)=CH-, -Y1-CH(R4)=CH-CH2-, -Y1-CH(R4)-CH=CH-, -Y1-CH(R4)=CH-CH2-CH2-, o ûY1-CH2-CH(R4)-, en el cual, cuando sea posible, opcionalmente uno o dos átomos de hidrogeno del mismo o diferente átomo de carbono o nitrogeno pueden ser reemplazados por hidroxilo, C1-4alquiloxiC1-4alquilo, alquilcarbonilo de C1-4 o alquilo de C1-6 sustituidos opcionalmente con halogeno, hidroxilo, cicloalquilo de C3-6 o fenilo; Y1 es oxígeno o azufre; Alk1 es alquilcarbonilo de C1-4, carbonilo C1-4alquilo, C1-4 alquilcarbonilC1-4alquilo, carbonilo o alcandiilo de C1-6 sustituido opcionalmente con hidroxilo, halogeno, amino, hidroxiC1-4alquilo, alquiloxi de C1-4 hidroxicarbonilo, alquiloxicarbonilo de C1-4, aminocarbonilo, mono- o di(C1-4alquil)amino-carbonilo, C1-4alquiloxiC1-4alquilo, C1-4alquilcarboniloxi, C1-4alquilcarboniloxiC1-4alquilocarboniloxi, C1-4alquiloxiimino, fenilC1-4alquilamino, C1-4alquiloxicarboniloC4-6alquenilo, ciano C1-6 alquenilo o C1-6cicloalquil-carboniloxiC1-4alquiloxicarboniloxi; R1, R2 y R3 se seleccionan cada independientemente entre hidrogeno, alquilo, de C1-6 alquenilo de C3-6 alquiloxi de C1-6 hidroxicarbonilo, trihalometilo, trihalometoxi, halogeno, hidroxilo, ciano, nitro, amino, C1-6alquilcarbonilamino, C1-6alquiloxicarbonilo, C1-4alquiloxicarboniloxi, aminocarbonilo, monoû o di(C1-6alquil)aminocarbonilo, aminoalquilo de C1-6 mono- o di(C1-6alquil)aminoC1-6alquilo, C1-4alquilcarboniloxiC1-4alquiloxicarboniloxi o C3-6cicloalquilcarboniloxiC1-4alquiloxicarboniloxi; R4 es hidrogeno, hidroxicarbonilo, fenilo, aminicarbonilo, mono- o di(C1-4alquil)aminocarbonilo, C1-4alquiloxiC1-4alquilo, C1-4alquiloxicarbonilo, N-pirrolidincarbonilo, N-piperidinilcarbonilo, N-homopiperidinilcarbonilo, C1-4alquilcarboniloxiC1-4alquiloxicarbonilo, C1-4alquiloxicarbonilC1-4alquilo, C3-6cicloalquilcarboniloxiC1-4alquiloxicarboniloxi o C1-6alquilo opcionalmente sustituido con hidroxilo, ciano, amino, fenilo, monoû o di(C1-4alquil)amino o mono- o di(C1-4alquil)aminocarbonilo; -A- es un radical bivalente de formulas (2) a (8) en las cuales m es 0 o 1; Alk2 es un radical bivalente seleccionado entre C1-4alquilcarbonilC1-4alquilo; fenilo; C3-6cicloalquilcarboniloxiC1-4alquiloxicarboniloxi; C3-6cicloalcandiilo sustituido opcionalmente con uno o más halogenos, hidroxilo, hidroxicarbonilo, hidroxiC1-4alquilo, alquiloxi de C1-4, C1-4alquiloxiC1-4alquilo, C1-4alquiloxicarbonilo, C1-4alquilcarboniloxiC1-4alquiloxicarboniloxi, C3-6cicloalquilcarboniloxiC1-4alquiloxicarboniloxi, fenilo; o alquilo de C1-6 sustituido opcionalmente con uno o más hidroxilos, halogeno, amino, hidroxicarbonilo, hidroxiC1-4alquilo, alquiloxi de C1-4, C1-4alquiloxiC1-4alquilo, C1-4alquiloxicarbonilo, C1-4alquilcarboniloxiC1-4alquiloxicarboniloxi, cicloalquilo de C3-6, aminocarbonilo, mono- o di(C1-4alquil)aminocarbonilo o alquilo de C1-6 en el cual el alquilo de C1-6 conjuntamente con el átomo de carbono al cual está unido puede formar un cicloalquilo de C3-6; R6 es hidrogeno, alquilo de C1-4, halogeno, hidroxilo, hidroxialquilo de C1-4, alquiloxi de C1-4 aminoalquilo de C1-4, alquiloxicarbonilo de C1-4, C1-4alquilcarboniloxiC1-4alquiloxicarbonilo, amino, hidroxicarbonilo, aminocarbonilo, mono- o di(C1-4alquil)aminocarbonilo o C3-6cicloalquilcarboniloxiC1-4alquiloxicarboniloxi; R5 es un radical de formulas (9) a (13) en las cuales n es 1 o 2, p1 es 0 y p2 es 1 o 2; o p1 es 1 o 2 y p2 es 0; X es oxígeno, azufre, NR9 o CHNO2; Y2 es oxígeno o azufre; R7 es hidrogeno, alquilo de C1-6, cicloalquilo de C3-6, fenilo o fenilmetilo; R8 es alquilo de C1-6, cicloalquilo de C3-6, fenilo o fenilmetilo; R9 es ciano, alquilo de C1-6, cicloalquilo de C3-6, alquiloxicarbonilo de C1-6 o aminocarbonilo; R10 es hidrogeno o alquilo de C1-6; o R9 y R10 tomados conjuntamente con el átomo de nitrogeno al cual están unidos pueden formar un grupo pirrolidinilo, piperidinilo, homopiperidinilo, piperazinilo o morfolinilo, sustituido opcionalmente con alquilo de C1-4 o alquiloxi de C1-4; y Q es un radical bivalente de formulas: -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2-, -CH=CH-, -CH2-CO-, -CO-CH2-, -(CH2)2-CO-, -CO-(CH2)2-, -CO-CH2-CO-, -CH2-CO-CH2-, en las cuales opcionalmente uno o dos átomos de hidrogeno del mismo o diferente átomo de carbono pueden estar reemplazados por alquilo de C1-4, hidroxilo o fenilo, o Q es un radical bivalente de formulas (14) o (15). Estos compuestos son utiles para restaurar el acomodamiento fundico alterado. También se dan a conocer: composiciones farmacéuticas que los comprenden, un proceso para preparar dichas composiciones y un proceso para preparar tales compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00202180 | 2000-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032158A1 true AR032158A1 (es) | 2003-10-29 |
Family
ID=8171674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102955A AR032158A1 (es) | 2000-06-22 | 2001-06-21 | Compuestos para tratar el desacomodamiento fundico, composiciones farmaceuticas que los comprenden, proceso para preparar dichas composiciones y proceso para preparar tales compuestos |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7081453B2 (es) |
| EP (1) | EP1296987B1 (es) |
| JP (1) | JP4911860B2 (es) |
| KR (1) | KR100821107B1 (es) |
| CN (2) | CN100516066C (es) |
| AR (1) | AR032158A1 (es) |
| AT (1) | ATE312104T1 (es) |
| AU (1) | AU783292B2 (es) |
| BG (1) | BG65895B1 (es) |
| BR (1) | BR0111859B1 (es) |
| CA (1) | CA2410233C (es) |
| CZ (1) | CZ305005B6 (es) |
| DE (1) | DE60115647T2 (es) |
| EA (1) | EA005760B1 (es) |
| EE (1) | EE04878B1 (es) |
| EG (1) | EG24462A (es) |
| ES (1) | ES2254467T3 (es) |
| HR (1) | HRP20020988B1 (es) |
| HU (1) | HU227398B1 (es) |
| IL (2) | IL153559A0 (es) |
| IS (1) | IS2618B (es) |
| JO (1) | JO2352B1 (es) |
| MX (1) | MXPA02012844A (es) |
| MY (1) | MY155267A (es) |
| NO (1) | NO328547B1 (es) |
| NZ (1) | NZ522519A (es) |
| PA (1) | PA8519601A1 (es) |
| PL (1) | PL201656B1 (es) |
| SA (1) | SA01220442B1 (es) |
| SK (1) | SK287730B6 (es) |
| UA (1) | UA74576C2 (es) |
| WO (1) | WO2001098306A1 (es) |
| ZA (1) | ZA200210303B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE256125T1 (de) | 1999-06-02 | 2003-12-15 | Janssen Pharmaceutica Nv | Aminoalkyl substituierte (benzodioxane, benzofurane oder benzopyrane) derivate |
| JP2003501428A (ja) | 1999-06-02 | 2003-01-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ピロリジニル、ピペリジニルもしくはホモピペリジニル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体 |
| JO2352B1 (en) * | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Compounds for the treatment of non-adaptation of the bottom of the uterus |
| JO2654B1 (en) * | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Multiple aryl caroxa amides are useful as lipid - lowering agents |
| JO2409B1 (en) | 2000-11-21 | 2007-06-17 | شركة جانسين فارماسوتيكا ان. في | Second-phenyl carboxy amides are useful as lipid-lowering agents |
| AU2004233863B2 (en) | 2003-04-24 | 2010-06-17 | Incyte Holdings Corporation | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| JP4896476B2 (ja) * | 2005-09-16 | 2012-03-14 | 広栄化学工業株式会社 | メチルオキシメチルアミノピリジン誘導体及びその製造方法 |
| US7999107B2 (en) | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| CA2685860A1 (en) * | 2007-05-10 | 2008-11-20 | Amr Technology, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| GEP201706656B (en) | 2011-11-11 | 2017-04-25 | Pfizer | 2-thiopyrimidinones |
| MA42035A (fr) | 2015-05-05 | 2018-03-14 | Pfizer | 2-thiopyrimidinones |
| CN105481839B (zh) * | 2015-11-23 | 2018-05-11 | 安徽千和新材料科技发展有限公司 | 一种光活性环氧啉对映体的制备方法 |
| EP3229193A1 (en) | 2016-04-07 | 2017-10-11 | The Boeing Company | A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910930A (en) * | 1973-01-04 | 1975-10-07 | Janssen Pharmaceutica Nv | 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones |
| DE2400049A1 (de) * | 1974-01-02 | 1975-07-10 | Spumalit Anstalt | Transportkasten aus kunststoff, insbesondere fuer flaschen |
| GR71865B (es) | 1978-03-20 | 1983-07-07 | Ciba Geigy | |
| US4329348A (en) * | 1979-02-26 | 1982-05-11 | Ciba-Geigy Corporation | N-Oxacyclic-alkylpiperidines as psychostimulants |
| EP0144101B1 (en) * | 1983-11-30 | 1991-02-06 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines |
| SI9300097B (en) | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
| ZA931343B (en) | 1992-03-06 | 1993-09-24 | Akzo Nv | 1,4-dioxino(2,3-b)pyridine derivatives. |
| US6403103B1 (en) * | 1994-08-12 | 2002-06-11 | Bio Merieux | Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease |
| FR2744451B1 (fr) * | 1996-02-01 | 1998-04-24 | Pf Medicament | Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique |
| US6133277A (en) * | 1997-12-05 | 2000-10-17 | Janssen Pharmaceutica N.V. | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| ATE256125T1 (de) | 1999-06-02 | 2003-12-15 | Janssen Pharmaceutica Nv | Aminoalkyl substituierte (benzodioxane, benzofurane oder benzopyrane) derivate |
| JP2003501428A (ja) | 1999-06-02 | 2003-01-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ピロリジニル、ピペリジニルもしくはホモピペリジニル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体 |
| TWI225488B (en) * | 1999-12-21 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivatives of homopiperidinyl substituted benzimidazole analogues |
| JO2352B1 (en) * | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Compounds for the treatment of non-adaptation of the bottom of the uterus |
-
2001
- 2001-05-29 JO JO200184A patent/JO2352B1/en active
- 2001-06-13 DE DE60115647T patent/DE60115647T2/de not_active Expired - Lifetime
- 2001-06-13 JP JP2002504262A patent/JP4911860B2/ja not_active Expired - Fee Related
- 2001-06-13 NZ NZ522519A patent/NZ522519A/en not_active IP Right Cessation
- 2001-06-13 CA CA2410233A patent/CA2410233C/en not_active Expired - Fee Related
- 2001-06-13 ES ES01962742T patent/ES2254467T3/es not_active Expired - Lifetime
- 2001-06-13 WO PCT/EP2001/006749 patent/WO2001098306A1/en not_active Ceased
- 2001-06-13 HU HU0301185A patent/HU227398B1/hu not_active IP Right Cessation
- 2001-06-13 MX MXPA02012844A patent/MXPA02012844A/es active IP Right Grant
- 2001-06-13 CN CNB200510113576XA patent/CN100516066C/zh not_active Expired - Fee Related
- 2001-06-13 AT AT01962742T patent/ATE312104T1/de not_active IP Right Cessation
- 2001-06-13 BR BRPI0111859-5A patent/BR0111859B1/pt not_active IP Right Cessation
- 2001-06-13 KR KR1020027014679A patent/KR100821107B1/ko not_active Expired - Fee Related
- 2001-06-13 UA UA20021210045A patent/UA74576C2/uk unknown
- 2001-06-13 HR HR20020988A patent/HRP20020988B1/xx not_active IP Right Cessation
- 2001-06-13 EE EEP200200694A patent/EE04878B1/xx not_active IP Right Cessation
- 2001-06-13 IL IL15355901A patent/IL153559A0/xx active IP Right Grant
- 2001-06-13 CZ CZ2003-115A patent/CZ305005B6/cs not_active IP Right Cessation
- 2001-06-13 SK SK49-2003A patent/SK287730B6/sk not_active IP Right Cessation
- 2001-06-13 US US10/311,612 patent/US7081453B2/en not_active Expired - Lifetime
- 2001-06-13 CN CNB018116108A patent/CN1288157C/zh not_active Expired - Fee Related
- 2001-06-13 EP EP01962742A patent/EP1296987B1/en not_active Expired - Lifetime
- 2001-06-13 PL PL358886A patent/PL201656B1/pl unknown
- 2001-06-13 AU AU83864/01A patent/AU783292B2/en not_active Ceased
- 2001-06-13 EA EA200300049A patent/EA005760B1/ru not_active IP Right Cessation
- 2001-06-14 PA PA20018519601A patent/PA8519601A1/es unknown
- 2001-06-20 MY MYPI20012913A patent/MY155267A/en unknown
- 2001-06-20 EG EG20010661A patent/EG24462A/xx active
- 2001-06-21 AR ARP010102955A patent/AR032158A1/es active IP Right Grant
- 2001-10-10 SA SA1220442A patent/SA01220442B1/ar unknown
-
2002
- 2002-10-25 IS IS6591A patent/IS2618B/is unknown
- 2002-11-25 BG BG107313A patent/BG65895B1/bg unknown
- 2002-12-19 IL IL153559A patent/IL153559A/en not_active IP Right Cessation
- 2002-12-19 ZA ZA200210303A patent/ZA200210303B/en unknown
- 2002-12-23 NO NO20026219A patent/NO328547B1/no not_active IP Right Cessation
-
2006
- 2006-02-16 US US11/355,402 patent/US7423048B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| AR065772A1 (es) | Compuestos de indolobenzazepina para el tratamiento de la hepatitis c. composiciones farmaceuticas. | |
| ES2128092T3 (es) | Derivados de anilina. | |
| AR035497A1 (es) | Compuestos no-imidazol, composicion farmaceutica que los comprenden y el uso de los mismos para la preparacion de medicamentos | |
| CO4650042A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
| AR034390A1 (es) | Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa | |
| AR014785A1 (es) | Derivados de pirimidina, uso de dichos derivados para la preparacion de medicamentos para el tratamiento de hiv,composicion farmaceutica que los comprende,procedimiento para prepararla, procedimiento para preparar dichos derivados, e intermediarios utiles en la preparacion de dichos derivados. | |
| AR039565A1 (es) | Derivados de piperazinilo, piperidinilo y morfolinilo como inhibidores de desacetilasa de histona, composicion farmaceutica que los contiene y procedimiento de preparacion de ambos | |
| AR035557A1 (es) | Un metodo para el tratamiento de desordenes proliferativos de las celulas asociadas con una actividad alterada de la cinasa dependiente de las celulas, un derivado de 3-ureido-pirazol, un procedimiento para su preparacion y una composicion farmaceutica que comprende dicho derivado | |
| BG104372A (en) | (benzodioxan, benzofuran or benzopyran) derivatives possessing fundus relaxing properties | |
| PE20071136A1 (es) | Derivados de anilina sustituida como antagonistas de la histamina h3 | |
| CO5580747A2 (es) | Derivados e intermediarios de n-adamantilmetilo como composiciones farmaceuticas y procesos para su preparacion | |
| UY28578A1 (es) | Derivados de amida | |
| UY28526A1 (es) | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos | |
| AR061918A1 (es) | Compuesto biciclico que contiene nitrogeno, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende | |
| YU108791A (sh) | Pirazolopirimidinon antianginalna jedinjenja | |
| AR050902A1 (es) | Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion | |
| PE20040949A1 (es) | DERIVADOS DE HEXAHIDRO-PIRAZINO [1,2-a] PIRIMIDIN-4,7-DIONA SUSTITUIDOS EN POSICION 3 POR NITROGENO Y PROCEDIMIENTO PARA LA PREPARACION DE LA COMPOSICION FARMACEUTICA | |
| AR035065A1 (es) | Derivados de quinolina y quinolinona, uso de dichos compuestos en la fabricacion de medicamentos, composiciones farmaceuticas que comprenden dichos compuestos, proceso para preparar dichas composiciones y procedimiento para la preparacion de dichos compuestos | |
| ES2143238T3 (es) | Derivados de 1-(piperidinil disustituido en posiciones 1,2)-piperazinas sustituidas en posicion 4. | |
| UA26401C2 (uk) | Заміщеhі 3-аміhохіhуклідиhи | |
| NZ502209A (en) | Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | |
| MY121852A (en) | 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders | |
| AR034547A1 (es) | Derivados de indolin-2-ona, su utilizacion, procedimiento para su preparacion, composicion farmaceutica que lo contiene, medicamento que consiste en dicho derivado, y un producto que contiene dicho derivado y un antagonista de los receptores de la vasopresina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |